Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects

被引：31

作者：

Shi, Huan ^{[1
]}

Sun, Meili ^{[2
]}

Liu, Lin ^{[1
]}

Wang, Zhehai ^{[1
]}

机构：

[1] Shandong Canc Hosp & Inst, Dept Oncol, Jinan 250117, Shandong, Peoples R China

[2] Shandong Univ, Jinan Cent Hosp, Dept Oncol, Jinan 250013, Shandong, Peoples R China

来源：

MOLECULAR CANCER | 2014年 / 13卷

基金：

美国国家科学基金会;

关键词：

Adoptive transfer; Chimeric antigen receptor; Gene transfer; T cells; HUMAN T-CELLS; CYTOKINE RELEASE SYNDROME; IN-VIVO PERSISTENCE; ANTITUMOR-ACTIVITY; SIGNALING DOMAIN; PHASE-I; GENETIC-MODIFICATION; TUMOR-LOCALIZATION; ANTI-PD-1; ANTIBODY; CLINICAL-TRIAL;

D O I：

10.1186/1476-4598-13-219

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Chimeric antigen receptors (CARs) are recombinant receptors that combine the specificity of an antigen-specific antibody with the T-cell's activating functions. Initial clinical trials of genetically engineered CAR T cells have significantly raised the profile of T cell therapy, and great efforts have been made to improve this approach. In this review, we provide a structural overview of the development of CAR technology and highlight areas that require further refinement. We also discuss critical issues related to CAR therapy, including the optimization of CAR T cells, the route of administration, CAR toxicity and the blocking of inhibitory molecules.

引用

页数：8

共 90 条

[71] Redirecting specificity of T-cell Populations for CD19 using the Sleeping beauty system [J].

Singh, Harjeet ;

Manuri, Pallavi R. ;

Olivares, Simon ;

Dara, Navid ;

Dawson, Margaret J. ;

Huls, Helen ;

Hackett, Perry B. ;

Kohn, Donald B. ;

Shpall, Elizabeth J. ;

Champlin, Richard E. ;

Cooper, Laurence J. N. .

CANCER RESEARCH, 2008, 68 (08) :2961-2971

[72] Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors - design, biosafety, and production [J].

Sinn, PL ;

Sauter, SL ;

McCray, PL .

GENE THERAPY, 2005, 12 (14) :1089-1098

[73] Chimeric NKG2D CAR-Expressing T Cell-Mediated Attack of Human Ovarian Cancer Is Enhanced by Histone Deacetylase Inhibition [J].

Song, De-Gang ;

Ye, Qunrui ;

Santoro, Stephen ;

Fang, Chongyun ;

Best, Andrew ;

Powell, Daniel J., Jr. .

HUMAN GENE THERAPY, 2013, 24 (03) :295-305

[74] CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo [J].

Song, De-Gang ;

Ye, Qunrui ;

Poussin, Mathilde ;

Harms, Gretchen M. ;

Figini, Mariangela ;

Powell, Daniel J., Jr. .

BLOOD, 2012, 119 (03) :696-706

[75] In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB) [J].

Song, De-Gang ;

Ye, Qunrui ;

Carpenito, Carmine ;

Poussin, Mathilde ;

Wang, Li-Ping ;

Ji, Chunyan ;

Figini, Mariangela ;

June, Carl H. ;

Coukos, George ;

Powell, Daniel J., Jr. .

CANCER RESEARCH, 2011, 71 (13) :4617-4627

[76] Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies [J].

Tamada, Koji ;

Geng, Degui ;

Sakoda, Yukimi ;

Bansal, Navneeta ;

Srivastava, Ratika ;

Li, Zhaoyang ;

Davila, Eduardo .

CLINICAL CANCER RESEARCH, 2012, 18 (23) :6436-6445

[77] Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells [J].

Till, Brian G. ;

Jensen, Michael C. ;

Wang, Jinjuan ;

Chen, Eric Y. ;

Wood, Brent L. ;

Greisman, Harvey A. ;

Qian, Xiaojun ;

James, Scott E. ;

Raubitschek, Andrew ;

Forman, Stephen J. ;

Gopal, Ajay K. ;

Pagel, John M. ;

Lindgren, Catherine G. ;

Greenberg, Philip D. ;

Riddell, Stanley R. ;

Press, Oliver W. .

BLOOD, 2008, 112 (06) :2261-2271

[78] CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results [J].

Till, Brian G. ;

Jensen, Michael C. ;

Wang, Jinjuan ;

Qian, Xiaojun ;

Gopal, Ajay K. ;

Maloney, David G. ;

Lindgren, Catherine G. ;

Lin, Yukang ;

Pagel, John M. ;

Budde, Lihua E. ;

Raubitschek, Andrew ;

Forman, Stephen J. ;

Greenberg, Philip D. ;

Riddell, Stanley R. ;

Press, Oliver W. .

BLOOD, 2012, 119 (17) :3940-3950

[79] Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer [J].

Topalian, Suzanne L. ;

Hodi, F. Stephen ;

Brahmer, Julie R. ;

Gettinger, Scott N. ;

Smith, David C. ;

McDermott, David F. ;

Powderly, John D. ;

Carvajal, Richard D. ;

Sosman, Jeffrey A. ;

Atkins, Michael B. ;

Leming, Philip D. ;

Spigel, David R. ;

Antonia, Scott J. ;

Horn, Leora ;

Drake, Charles G. ;

Pardoll, Drew M. ;

Chen, Lieping ;

Sharfman, William H. ;

Anders, Robert A. ;

Taube, Janis M. ;

McMiller, Tracee L. ;

Xu, Haiying ;

Korman, Alan J. ;

Jure-Kunkel, Maria ;

Agrawal, Shruti ;

McDonald, Daniel ;

Kollia, Georgia D. ;

Gupta, Ashok ;

Wigginton, Jon M. ;

Sznol, Mario .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2443-2454

[80] Highly efficient redirected anti-tumor activity of human lymphocytes transduced with a completely human chimeric immune receptor [J].

Turatti, F ;

Figini, M ;

Alberti, P ;

Willemsen, RA ;

Canevari, S ;

Mezzanzanica, D .

JOURNAL OF GENE MEDICINE, 2005, 7 (02) :158-170

← 1 2 3 4 5 6 7 8 9 →